Tag: Ascidian Therapeutics


Ascidian Therapeutics Launches With RNA Exon Editing Platform

October 12, 2022

Via: GEN

A new company, Ascidian Therapeutics, is launching with a focus on treating human diseases by rewriting RNA. With an initial focus on replacing mutated exons at the RNA level, Ascidian’s technology enables targeting of large genes and genes with high […]